| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87913 |
|
29,052 |
20,395 |
$4.42M |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
28,536 |
19,935 |
$3.96M |
| 86328 |
|
30,606 |
21,163 |
$1.31M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
49 |
49 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
46 |
32 |
$1K |
| 86769 |
|
30 |
30 |
$417.10 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
53 |
35 |
$0.00 |